Search Results

SEARCH RESULTS

Research Doesn’t End On A Medicine’s Approval

Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief medical officer shares why ongoing research helps us better…

READ MORE

Lifecycle from Brand to Generic

Where do generic drugs come from? Medicines have a long lifecycle from research to brand name drug to generic form. Over time, innovation leads to increased competition…

READ MORE

Innovation Spotlight: AbbVie Bioresearch Center in Worcester, Mass.

Biopharmaceutical innovation has emerged as a leading area of state economic development. Take Massachusetts, for example.

READ MORE

Researcher Profile: Laura Michael

Dr. Laura Michael started her career at Lilly researching cardiovascular disease and the complications that frequently arise from it.

READ MORE

A Decade of Innovation in Treatment for Multiple Sclerosis (MS) Patients

Ten years ago, treatments were limited to a handful of medicines. Today, MS patients have more treatment options with fewer side effects.

READ MORE

Brain Cancer: Research Brings Hope to a Difficult Disease

Between 1998 and 2014, there were 75 unsuccessful drugs and 3 approved drugs for brain cancer.

READ MORE

Cumulative Steps, Big Gains for Patients

Advances in treating debilitating diseases are often not the result of one single breakthrough, but rather an accumulation of knowledge and research over time.

READ MORE

Antiretroviral Treatments and Ensuing Innovations Prevent Almost 900,000 Premature HIV/AIDS Deaths

The introduction of HAART treatments caused a significant drop in the HIV/AIDS death rate.

READ MORE

How Can Biomarkers and Surrogate Endpoints Enhance R&D of Medicines?

In the age of personalized medicine, biomarkers are emerging as important tools in drug development.

READ MORE

America's Biopharmaceutical Industry Is Central to Diverse R&D Ecosystem

America's biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that supports continued medical advances for patients.

READ MORE